Applicability of a Genetic Signature for Enhanced Iloperidone Efficacy in the Treatment of Schizophrenia
Year: 2009
Type: article
DOI: 10.4088/jcp.08m04391
Institution: Vanda Pharmaceuticals (United States)
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2017802689
